Role of cetuximab in first-line treatment of metastatic colorectal cancer

The treatment of metastatic colorectal cancer (mCRC) has evolved considerably in the last decade, currently allowing most mCRC patients to live more than two years. Monoclonal antibodies targeting the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor play an important ro...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sotelo, Miguel Jhonatan, García-Paredes, Beatriz, Aguado, Carlos, Sastre, Javier, Díaz-Rubio, Eduardo
Формат: Artigo
Язык:Inglês
Опубликовано: Baishideng Publishing Group Co., Limited 2014
Предметы:
Topic Highlight
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989957/
https://ncbi.nlm.nih.gov/pubmed/24764659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i15.4208
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы